Research at our Charnwood site in the UK is focused on finding new medicines for respiratory diseases such as asthma, chronic bronchitis and emphysema as well as inflammatory diseases such as rheumatoid and osteoarthritis.

Employing over 1,300 people, Charnwood is a dedicated R&D site, encompassing all the major R&D functions including pharmaceutical and analytical R&D, process R&D, clinical and regulatory.

The Charnwood Clinical facilities include a hospital-based CPU (Clinical Pharmacology Unit) at Nottingham.

Read more about this facility.

Take a 360°  tour of this facility.